IGFBP7 might act as a tumor suppressor by inhibiting the proliferation of thyroid cancer cells via the downregulation of the activity of AKT, leading to an increase in the expression of the cell cycle inhibitors p27Kip1 and p21Cip1. This evidence concerns the gene AKT1 and neoplasm.